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Cell Stem Cell
Editors’ NotesHer Place in World History, and in Our Own
The death of Dr. Anne McLaren was met with great sadness and a sense of loss in the stem cell
community. We at CSC had the distinct pleasure of working with Anne to produce her Commentary
for our inaugural issue. In fact, her article is cited in this issue by the ISSCR Committee Forum
and the Eurostemcell Meeting report, both of which have been dedicated by the authors to
Dr. McLaren’s memory. We are also very happy to pay tribute to her many achievements with
an obituary written by her colleagues Professors Roger Pedersen and Brian Salter.
It’s All about Balance
Striking a successful balance of division, differentiation, and death is important for all stem cells, and their predominant
activity at any one time will vary, such as during development, in response to injury or to maintain homeostasis. Multiple
papers in this issue speak to the pathways utilized over a range of physiological contexts and of the consequences
when equilibrium is lost. Tothova and Gilliland have contributed a review of the roles played by FoxO family members in
stem cell function and disease. Chien’s lab demonstrates that the balance of Wnt signaling can tip the fate of cardiac pro-
genitors during heart formation by promoting the expansion of primitive cells and preventing their differentiation. Genera-
tion of mature cells may also be inhibited by blocking the cycling of stem cells, as shown by Lipton and colleagues in
a mouse model of HIV-associated dementia. Transgenic expression of gp120 led to the MAPK-dependent cell-cycle arrest
of adult neural progenitor cells, leaving them unable to contribute to neurogenesis. This stem cell-centric view into the
mechanism of a human viral pathology demonstrates why it is essential to uncover the range of mechanisms that control
stem cell balance.
Chimeras: Shock Value or Basic Tools?
Chimeras, organisms harboring cells from distinct sources, have become an essential tool for many as-
pects of stem cell science. We present a trio of articles that discuss varied issues relating to the generation
of human-animal chimeras. In this issue, the ISSCR Ethics Committee provides new guidelines for chimera
research in the Society section. In articles appearing online, Richard Behringer reviews the range of
systems in which human-animal chimeras have already been used, and in a Commentary article, George
Daley and colleagues provide an historical view of the teratoma assay and a suggestion that this technique
should be regulated by animal care committees, not ESCRO boards. Both of these articles will be included
in our September issue. An important distinction is that these pieces do not cover the generation of
hybrids, for example, by transfer of human nuclei to animal oocytes. This series underscores our intention
to publish material that will generate discourse, and we invite you to respond via the Correspondence
format.
Stem Cells at Work and at Home
The discovery of Drosophila gut stem cells with properties similar to those in the mamma-
lian intestine led to considerable excitement about their utility for analysis of stem cell
function. In this issue, Hou’s lab now describes renal and nephric stem cells (RNSCs) in
the fly Malpighian tubule, the functional equivalent of the kidney. The absence of an obvi-
ous cellular niche component, some evidence of tissue plasticity, and the relatively high
frequency of the population all point to a powerful new system in which to study regulatory,
and perhaps even epigenetic, control of stem cell function. The importance of studying
stem cells in their correct context and the difficulties of doing so in vertebrate systems
are highlighted by independent HSC studies from the Morrison and Eaves labs, also in
this issue. Whether RNSCs display uniformity in their stem cell traits, and how broadly applicable such findings will be
to mammalian tissues remain to be seen.
Much Ado about Something Important
An explosion of scientific and mainstream media coverage marked the coordinated release of three iPS reprogramming
papers, including that from Hochedlinger’s group in our inaugural issue. Given that iPS cells are solely murine, rely on im-
munogenic gene delivery systems, and are oncogenic in many cases, the media furor was called into question by some.
However, the fact that three independent groups, including the original lab, were all able to repeat, extend, and improve
on Takahashi and Yamanaka’s pioneering work is significant news. Does the existence of murine iPS cells obviate the
use of human blastocysts? Of course not. Many scientific and ethical issues remain and are not limited to the debates in
political circles. International discussion and consultation are essential, as highlighted by Bru¨stle and colleagues’ Meeting
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